Cesamet (Valeant Pharmaceuticals North America)
Welcome to the PulseAid listing for the Cesamet drug offered from Valeant Pharmaceuticals North America. This Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America |
| NON-PROPRIETARY NAME: | NABILONE |
| SUBSTANCE NAME: | NABILONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-11-01 |
| END MARKETING DATE: | 0000-00-00 |
Cesamet HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cesamet from Valeant Pharmaceuticals North America |
| LABELER NAME: | Valeant Pharmaceuticals North America |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 2009-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0187-1221_01c46f44-14ff-4510-89cb-84114ce439de |
| PRODUCT NDC: | 0187-1221 |
| APPLICATION NUMBER: | NDA018677 |
Other NABILONE Pharmaceutical Manufacturers / Labelers:
